Dufour, Jean-François

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2004


Lévy, Pierre L.; Duponchel, Sarah; Eischeid, Hannah; Molle, Jennifer; Michelet, Maud; Diserens, Gaëlle; Vermathen, Martina; Vermathen, Peter; Dufour, Jean-François; Dienes, Hans-Peter; Steffen, Hans-Michael; Odenthal, Margarete; Zoulim, Fabien; Bartosch, Birke (2017). Hepatitis C virus infection triggers a tumor-like glutamine metabolism. Hepatology, 65(3), pp. 789-803. Wiley Interscience 10.1002/hep.28949

Kolly, Philippe; Dufour, Jean-François (2017). Patients with hepatocellular carcinoma: Your address matters! Journal of hepatology, 66(3), pp. 480-481. Elsevier 10.1016/j.jhep.2016.11.026


Dufour, Jean-François (2016). Hepatology Highlights. Hepatology, 64(6), pp. 1829-1830. Wiley Interscience 10.1002/hep.28867

Dufour, Jean-François (2016). Hepatology Highlights. Hepatology, 64(5), pp. 1395-1397. Wiley Interscience 10.1002/hep.28828

Calo, Nicolas; Ramadori, Pierluigi; Sobolewski, Cyril; Romero, Yannick; Maeder, Christine; Fournier, Margot; Rantakari, Pia; Zhang, Fu-Ping; Poutanen, Matti; Dufour, Jean-François; Humar, Bostjan; Nef, Serge; Foti, Michelangelo (2016). Stress-activated miR-21/miR-21* in hepatocytes promotes lipid and glucose metabolic disorders associated with high-fat diet consumption. Gut, 65(11), pp. 1871-1881. BMJ Publishing Group 10.1136/gutjnl-2015-310822

Maan, Raoel; Zaim, Remziye; van der Meer, Adriaan J; Feld, Jordan J; Wedemeyer, Heiner; Dufour, Jean-François; Lammert, Frank; Manns, Michael P; Zeuzem, Stefan; Hansen, Bettina E; Janssen, Harry LA; Veldt, Bart J; de Knegt, Robert J; Uyl-de Groot, Carin A (2016). Real-world medical costs of antiviral therapy among patients with chronic HCV infection and advanced hepatic fibrosis. Journal of gastroenterology and hepatology, 31(11), pp. 1851-1859. Wiley-Blackwell Publishing Asia 10.1111/jgh.13373

Llovet, J; Merle, P; Weiss, KH; Yau, T; Ross, P; Mazzaferro, V; Blanc, JF; Ma, Y; Yen, C; Kocsis, J; Choo, S; Sukeepaisarnjaroen, W; Gerolami, R; Dufour, Jean-François; Gane, E; Ryoo, BY; Peck, M; Dao, T; Yeo, W; Lamlertthon, W; ... (November 2016). Phase II Studies with Refametinib or Refametinib Plus Sorafenib in Patients with Mutant RAS Hepatocellular Carcinoma (HCC). Hepatology, 64(1Suppl), 621A-621A. Wiley Interscience

Perazzo, Hugo; Dufour, Jean-François (2016). The therapeutic landscape of non-alcoholic steatohepatitis. (In Press). Liver international Wiley 10.1111/liv.13270

McPherson, Stuart; Hardy, Tim; Dufour, Jean-François; Petta, Salvatore; Romero-Gomez, Manuel; Allison, Mike; Oliveira, Claudia P; Francque, Sven; Van Gaal, Luc; Schattenberg, Jörn M; Tiniakos, Dina; Burt, Alastair; Bugianesi, Elisabetta; Ratziu, Vlad; Day, Christopher P; Anstee, Quentin M (2016). Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis. (In Press). The American journal of gastroenterology Nature Publishing Group 10.1038/ajg.2016.453

Dufour, Jean-François (2016). Hepatology Highlights. Hepatology, 64(4), pp. 1011-1013. Wiley Interscience 10.1002/hep.28764

Giudici, F; Bertisch, B; Negro, F; Stirnimann, G; Müllhaupt, B; Moradpour, D; Cerny, A; Dufour, Jean-François; Keiser, O (2016). Access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study: a person-centred approach. Journal of viral hepatitis, 23(9), pp. 697-707. Blackwell Science 10.1111/jvh.12535

Teufel, Andreas; Itzel, Timo; Erhart, Wiebke; Brosch, Mario; Wang, Xiao Yu; Kim, Yong Ook; von Schönfels, Witigo; Herrmann, Alexander; Brückner, Stefan; Stickel, Felix; Dufour, Jean-François; Chavakis, Triantafyllos; Hellerbrand, Claus; Spang, Rainer; Maass, Thorsten; Becker, Thomas; Schreiber, Stefan; Schafmayer, Clemens; Schuppan, Detlef and Hampe, Jochen (2016). Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients. Gastroenterology, 151(3), pp. 513-525. Elsevier 10.1053/j.gastro.2016.05.051

Dufour, Jean-François (2016). Hepatology Highlights. Hepatology, 64(3), pp. 703-705. Wiley Interscience 10.1002/hep.28725

Teufel, Andreas; Dufour, Jean-François (2016). Two-Step Forward Genetic Screen in Mice Identifies the Ral Pathway as a Central Drug Target in Hepatocellular Carcinoma. Gastroenterology, 151(2), pp. 231-233. Elsevier 10.1053/j.gastro.2016.06.034

Zeuzem, Stefan; Mantry, Parvez; Soriano, Vicente; Buynak, Robert J; Dufour, Jean-François; Pockros, Paul J; Wright, David; Angus, Peter; Buti, Maria; Stern, Jerry O; Kadus, Werner; Vinisko, Richard; Böcher, Wulf; Mensa, Federico J (2016). Short article: Faldaprevir, deleobuvir and ribavirin in IL28B non-CC patients with HCV genotype-1a infection included in the SOUND-C3 phase 2b study. European journal of gastroenterology & hepatology, 28(8), pp. 923-926. Lippincott Williams & Wilkins 10.1097/MEG.0000000000000649

Dufour, Jean-François (2016). Hepatology Highlights. Hepatology, 64(2), pp. 325-327. Wiley Interscience 10.1002/hep.28683

Zahnd, Cindy; Salazar-Vizcaya, Luisa; Dufour, Jean-François; Müllhaupt, Beat; Wandeler, Gilles; Kouyos, Roger; Estill, Janne; Bertisch, Barbara; Rauch, Andri; Keiser, Olivia (2016). Modelling the impact of deferring HCV treatment on liver-related complications in HIV coinfected men who have sex with men. Journal of hepatology, 65(1), pp. 26-32. Elsevier 10.1016/j.jhep.2016.02.030

Dufour, Jean-François (2016). Hepatology Highlights. Hepatology, 64(1), pp. 1-3. Wiley Interscience 10.1002/hep.28645

Manns, Michael; Samuel, Didier; Gane, Edward J; Mutimer, David; McCaughan, Geoff; Buti, Maria; Prieto, Martín; Calleja, José Luis; Peck-Radosavljevic, Markus; Müllhaupt, Beat; Agarwal, Kosh; Angus, Peter; Yoshida, Eric M; Colombo, Massimo; Rizzetto, Mario; Dvory-Sobol, Hadas; Denning, Jill; Arterburn, Sarah; Pang, Phillip S; Brainard, Diana; ... (2016). Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial. Lancet infectious diseases, 16(6), pp. 685-697. Elsevier 10.1016/S1473-3099(16)00052-9

Dufour, Jean-François (2016). Hepatology highlights. Hepatology, 63(6), pp. 1749-1751. Wiley Interscience 10.1002/hep.28605

Koeberle, D; Dufour, Jean-François; Demeter, G; Li, Q; Ribi, K; Samaras, P; Saletti, P; Roth, A D; Horber, D; Bühlmann, Michael; Wagner, A D; Montemurro, M; Lakatos, G; Feilchenfeldt, J; Peck-Radosavljevic, M; Rauch, D; Tschanz, B; Bodoky, G; Swiss Group for Clinical Cancer, SAKK (2016). Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29). Annals of oncology, 27(5), pp. 856-861. Oxford University Press 10.1093/annonc/mdw054

Dufour, Jean-François (2016). Hepatology highlights. Hepatology, 63(5), pp. 1405-1407. Wiley Interscience 10.1002/hep.28566

Martin, Juliette; Balmer, Maria Luisa; Rajendran, Saranya; Maurhofer, Olivier; Dufour, Jean-François; St-Pierre Dufour, Marie Vivien (2016). Nutritional stress exacerbates hepatic steatosis induced by deletion of the histidine nucleotide-binding (Hint2) mitochondrial protein. American journal of physiology - gastrointestinal and liver physiology, 310(7), G497-509. American Physiological Society 10.1152/ajpgi.00178.2015

Dufour, Jean-François (2016). Hepatology highlights. Hepatology, 63(4), pp. 1065-1067. Wiley Interscience 10.1002/hep.28498

Margini, Cristina; Dufour, Jean-François (2016). The story of HCC in NAFLD: from epidemiology, across pathogenesis, to prevention and treatment. Liver international, 36(3), pp. 317-324. Blackwell Munksgaard 10.1111/liv.13031

Foster, G R; Ferenci, P; Asselah, T; Mantry, P; Dufour, Jean-François; Dufour, Jean-François; Bourlière, M; Forton, D; Maevskaya, M; Wright, D; Yoshida, E M; García-Samaniego, J; Oliveira, C; Wright, M; Warner, N; Sha, N; Quinson, A-M; Stern, J O (2016). Open-label study of faldaprevir plus peginterferon and ribavirin in hepatitis C virus genotype 1-infected patients who failed placebo plus peginterferon and ribavirin. Journal of viral hepatitis, 23(3), pp. 227-231. Blackwell Science 10.1111/jvh.12485

Dufour, Jean-François (2016). Hepatology highlights. Hepatology, 63(3), pp. 679-681. Wiley Interscience 10.1002/hep.28454

Dufour, Jean-François (2016). Hepatology highlights. Hepatology, 63(2), pp. 351-353. Wiley Interscience 10.1002/hep.28402

Dufour, Jean-François (2016). Time to Abandon NASH? Hepatology, 63(1), pp. 9-10. Wiley Interscience 10.1002/hep.28276

Saran, Uttara; Humar, Bostjan; Kolly, Philippe; Dufour, Jean-François (2016). Hepatocellular carcinoma and lifestyles. Journal of hepatology, 64(1), pp. 203-214. Elsevier 10.1016/j.jhep.2015.08.028

Bechtel-Grosch, Ursina; Béguelin, Charles Antoine; Berezowska, Sabina Anna; Dufour, Jean-François; Takala, Jukka; Schefold, Joerg C. (2016). Fulminant hepatic and multiple organ failure following acute viral tonsillitis: a case report. Journal of medical case reports, 10(7), p. 7. BioMed Central 10.1186/s13256-015-0777-3

Kolly, Philippe; Dufour, Jean-François (2016). Reply to «Lack of evidence of an effect of Direct Acting Antivirals on the recurrence of hepatocellular carcinoma: The ANRS collaborative study group on hepatocellular carcinoma (ANRS CO22 HEPATHER, CO12 CIRVIR and CO23 CUPILT cohorts)». Journal of hepatology, 65(6), pp. 1268-1269. Elsevier 10.1016/j.jhep.2016.07.032

Kolly, Philippe; Dufour, Jean-François (2016). Surveillance for Hepatocellular Carcinoma in Patients with NASH. Diagnostics, 6(2), p. 22. MDPI 10.3390/diagnostics6020022

Munteanu, M.; Tiniakos, D.; Anstee, Q.; Charlotte, F.; Marchesini, G.; Bugianesi, E.; Trauner, M.; Romero Gomez, M.; Oliveira, C.; Day, C.; Dufour, Jean-François; Bellentani, S.; Ngo, Y.; Traussnig, S.; Perazzo, H.; Deckmyn, O.; Bedossa, P.; Ratziu, V.; Poynard, T. (2016). Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference. Alimentary pharmacology & therapeutics, 44(8), pp. 877-889. Wiley-Blackwell 10.1111/apt.13770

Scherer, Antonia; Dufour, Jean-François (2016). Treatment of Non-Alcoholic Fatty Liver Disease. Digestive diseases, 34(Suppl. 1), pp. 27-31. Karger 10.1159/000447278


Buhler, Stéphane; Giostra, Emiliano; Gbame, Corinne; de Rham, Casimir; Mullhaupt, Beat; Dufour, Jean-François; Majno, Pietro; Negro, Francesco; Bochud, Pierre-Yves; Villard, Jean (2015). A significant effect of the KIR ligand HLA-C on fibrosis progression in chronic C hepatitis with or without liver transplantation. Liver international, 36(9), n/a-n/a. Blackwell Munksgaard 10.1111/liv.13057

Dufour, Jean-François (2015). Hepatology highlights. Hepatology, 63(1), pp. 1-3. Wiley Interscience 10.1002/hep.28354

Kolly, Philippe; Reeves, Helen; Sangro, Bruno; Knöpfli, Marina Janusheva; Candinas, Daniel; Dufour, Jean-François (2015). Assessment of the Hong Kong Liver Cancer Staging System in Europe. Liver international, 36(6), pp. 911-917. Blackwell Munksgaard 10.1111/liv.13045

Quteineh, L; Bochud, P-Y; Golshayan, D; Crettol, S; Venetz, J-P; Manuel, O; Kutalik, Z; Treyer, A; Lehmann, R; Mueller, N J; Binet, I; van Delden, C; Steiger, J; Mohacsi, P; Dufour, Jean-François; Soccal, P M; Pascual, M; Semmo, Nasser; Beldi, Guido and Eap, C B (2015). CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation. Pharmacogenomics journal, 17(1), pp. 69-75. Nature Publishing Group 10.1038/tpj.2015.82

van der Meer, Adriaan J; Maan, Raoel; Veldt, Bart J; Feld, Jordan J; Wedemeyer, Heiner; Dufour, Jean-François; Lammert, Frank; Duarte-Rojo, Andres; Manns, Michael P; Zeuzem, Stefan; Peter Hofmann, W; de Knegt, Robert J; Hansen, Bettina E; Janssen, Harry L A (2015). Improvement of platelets after SVR among patients with chronic HCV infection and advanced hepatic fibrosis. Journal of gastroenterology and hepatology, 31(6), pp. 1168-1176. Wiley-Blackwell Publishing Asia 10.1111/jgh.13252

Wang, Qixia; Sachse, Karl Philip; Semmo, M; Lokhande, Megha; Montani, Matteo; Dufour, Jean-François; Zoulim, F; Klenerman, Paul; Semmo, Nasser (2015). T- and B-cell responses and previous exposure to hepatitis B virus in 'anti-HBc alone' patients. Journal of viral hepatitis, 22(12), pp. 1068-1078. Blackwell Science 10.1111/jvh.12428

Bartella, Isabel; Dufour, Jean-François (2015). Clinical Diagnosis and Staging of Intrahepatic Cholangiocarcinoma. Journal of gastrointestinal and liver diseases, 24(4), pp. 481-489. Medical University Press 10.15403/jgld.2014.1121.244.chl

Dufour, Jean-François (2015). Hepatology highlights. Hepatology, 62(6), pp. 1649-1651. Wiley Interscience 10.1002/hep.28288

Saran, Uttara; Foti, Michelangelo; Dufour, Jean-François (2015). Cellular and molecular effects of the mTOR inhibitor everolimus. Clinical science, 129(10), pp. 895-914. Portland 10.1042/CS20150149

Wang, Hui; El Maadidi, Souhayla; Fischer, Janett; Grabski, Elena; Dickhöfer, Sabine; Klimosch, Sascha; Flannery, Sinead M; Filomena, Angela; Wolz, Olaf-Oliver; Schneiderhan-Marra, Nicole; Löffler, Markus W; Wiese, Manfred; Pichulik, Tica; Müllhaupt, Beat; Semela, David; Dufour, Jean-François; Bochud, Pierre-Yves; Bowie, Andrew G; Kalinke, Ulrich; Berg, Thomas; ... (2015). A frequent hypofunctional IRAK2 variant is associated with reduced spontaneous hepatitis C virus clearance. Hepatology, 62(5), pp. 1375-1387. Wiley Interscience 10.1002/hep.28105

Dufour, Jean-François (2015). Hepatology highlights. Hepatology, 62(5), pp. 1331-1333. Wiley Interscience 10.1002/hep.28161

Dufour, Jean-François (2015). Hepatology highlights. Hepatology, 62(4), pp. 985-987. Wiley Interscience 10.1002/hep.28127

Berzigotti, Annalisa; Saran, Uttara; Dufour, Jean-François (2015). Physical activity and liver diseases. Hepatology, 63(3), pp. 1026-1040. Wiley Interscience 10.1002/hep.28132

Dufour, Jean-François (2015). Hepatology highlights. Hepatology, 62(3), pp. 663-665. Wiley Interscience 10.1002/hep.27995

Pocha, Christine; Kolly, Philippe; Dufour, Jean-François (2015). Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: A Problem of Growing Magnitude. Seminars in liver disease, 35(3), pp. 304-317. Thieme Medical Publishers 10.1055/s-0035-1562949

Dufour, Jean-François (2015). Hepatology highlights. Hepatology, 62(2), pp. 327-329. Wiley Interscience 10.1002/hep.27933

Piguet, Anne-Christine; Medova, Michaela; Keogh, Adrian; Glück, Astrid Andreina; Aebersold, Daniel; Dufour, Jean-François; Dufour, Jean-François; Zimmer, Yitzhak (2015). Impact of MET targeting on tumor-associated angiogenesis and growth of MET mutations-driven models of liver cancer. Genes & cancer, 6(7-8), pp. 317-327. Impact Journals

Zhu, Andrew X; Park, Joon Oh; Ryoo, Baek-Yeol; Yen, Chia-Jui; Poon, Ronnie; Pastorelli, Davide; Blanc, Jean-Frederic; Chung, Hyun Cheol; Baron, Ari D; Pfiffer, Tulio Eduardo Flesch; Okusaka, Takuji; Kubackova, Katerina; Trojan, Jorg; Sastre, Javier; Chau, Ian; Chang, Shao-Chun; Abada, Paolo B; Yang, Ling; Schwartz, Jonathan D; Kudo, Masatoshi; ... (2015). Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial. The lancet oncology, 16(7), pp. 859-870. Elsevier 10.1016/S1470-2045(15)00050-9

Dufour, Jean-François (2015). Hepatology highlights. Hepatology, 62(1), pp. 1-3. Wiley Interscience 10.1002/hep.27898

Dufour, Jean-François (2015). Hepatology highlights. Hepatology, 61(6), pp. 1773-1775. Wiley Interscience 10.1002/hep.27848

Dufour, Jean-François (2015). Hepatology highlights. Hepatology, 61(5), pp. 1449-1451. Wiley Interscience 10.1002/hep.27788

Dufour, Jean-François (2015). Hepatology highlights. Hepatology, 61(4), pp. 1101-1103. Wiley Interscience 10.1002/hep.27749

Toso, Christian; Meeberg, Glenda; Hernandez-Alejandro, Roberto; Dufour, Jean-François; Marotta, Paul; Majno, Pietro; Kneteman, Norman M (2015). Total Tumor Volume and Alpha Fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation. Hepatology, 62(1), pp. 158-165. Wiley Interscience 10.1002/hep.27787

Dufour, Jean-François (2015). Hepatology highlights. Hepatology, 61(3), pp. 741-743. Wiley Interscience 10.1002/hep.27692

Maan, Raoel; van der Meer, Adriaan J; Hansen, Bettina E; Feld, Jordan J; Wedemeyer, Heiner; Dufour, Jean-François; Lammert, Frank; Manns, Michael P; Zeuzem, Stefan; Janssen, Harry L A; de Knegt, Robert J; Veldt, Bart J (2015). Risk of infections during interferon-based treatment in patients with chronic HCV infection and advanced hepatic fibrosis. Journal of gastroenterology and hepatology, 30(6), pp. 1057-1064. Wiley-Blackwell Publishing Asia 10.1111/jgh.12929

van der Meer, Adriaan J; Hansen, Bettina E; Fattovich, Giovanna; Feld, Jordan J; Wedemeyer, Heiner; Dufour, Jean-François; Lammert, Frank; Duarte-Rojo, Andres; Manns, Michael P; Ieluzzi, Donatella; Zeuzem, Stefan; Hofmann, W Peter; de Knegt, Robert J; Veldt, Bart J; Janssen, Harry L A (2015). Reliable prediction of clinical outcome in patients with chronic HCV infection and compensated advanced hepatic fibrosis: a validated model using objective and readily available clinical parameters. Gut, 64(2), pp. 322-331. BMJ Publishing Group 10.1136/gutjnl-2013-305357

Zeuzem, Stefan; Dufour, Jean-François; Buti, Maria; Soriano, Vicente; Buynak, Robert J; Mantry, Parvez; Taunk, Jawahar; Stern, Jerry O; Vinisko, Richard; Gallivan, John-Paul; Böcher, Wulf; Mensa, Federico J (2015). Interferon-free treatment of chronic hepatitis C with faldaprevir, deleobuvir and ribavirin: SOUND-C3, a Phase 2b study. Liver international, 35(2), pp. 417-421. Blackwell Munksgaard 10.1111/liv.12693

Dufour, Jean-François (2015). Hepatology highlights. Hepatology, 61(1), pp. 1-3. Wiley Interscience 10.1002/hep.27602

Piguet, Anne Christine; Saran, Uttara; Simillion, Cedric André Marie; Keller, Irene; Terracciano, Luigi; Reeves, Helen L; Dufour, Jean-François (2015). Regular exercise decreases liver tumors development in hepatocyte-specific PTEN-deficient mice independently of steatosis. Journal of hepatology, 62(6), pp. 1296-1303. Elsevier 10.1016/j.jhep.2015.01.017

Diserens, Gaëlle; Vermathen, Martina; Precht, Maria Christina; Broskey, N T; Boesch, Chris; Amati, F; Dufour, Jean-François; Vermathen, Peter (2015). Separation of small metabolites and lipids in spectra from biopsies by diffusion-weighted HR-MAS NMR: a feasibility study. The Analyst, 140(1), pp. 272-279. Royal Society of Chemistry 10.1039/c4an01663g

Ferenci, Peter; Asselah, Tarik; Foster, Graham R; Zeuzem, Stefan; Sarrazin, Christoph; Moreno, Christophe; Ouzan, Denis; Maevskaya, Marina; Calinas, Filipe; Morano, Luis E; Crespo, Javier; Dufour, Jean-François; Bourlière, Marc; Agarwal, Kosh; Forton, Daniel; Schuchmann, Marcus; Zehnter, Elmar; Nishiguchi, Shuhei; Omata, Masao; Kukolj, George; ... (2015). STARTVerso1: A randomized trial of faldaprevir plus pegylated interferon/ribavirin for chronic HCV genotype-1 infection. Journal of hepatology, 62(6), pp. 1246-1255. Elsevier 10.1016/j.jhep.2014.12.024

Zochowska, Monika; Piguet, Anne Christine; Jemielity, Jacek; Kowalska, Joanna; Szolajska, Ewa; Dufour, Jean-François; Chroboczek, Jadwiga (2015). Virus-like particle-mediated intracellular delivery of mRNA cap analog with in vivo activity against hepatocellular carcinoma. Nanomedicine : nanotechnology, biology, and medicine, 11(1), pp. 67-76. Elsevier 10.1016/j.nano.2014.07.009

Dufour, Jean-François (2015). Hepatology highlights. Hepatology, 61(2), pp. 411-412. Wiley Interscience 10.1002/hep.27652

Richani, Mandy; Kolly, Philippe; Knoepfli, Marina; Herrmann, Evelyn; Zweifel, Martin; Von Tengg-Kobligk, Hendrik; Candinas, Daniel; Dufour, Jean-François (2015). Treatment allocation in hepatocellular carcinoma: Assessment of the BCLC algorithm. Annals of hepatology, 15(1), pp. 82-90. Sociedad Mexicana de Hepatologia 10.5604/16652681.1184233

Wandeler, Gilles; Dufour, Jean-François; Bruggmann, Philip; Rauch, Andri (2015). Hepatitis C: a changing epidemic. Swiss medical weekly, 145, w14093. EMH Schweizerischer Ärzteverlag 10.4414/smw.2015.14093

Hirzel, Cédric; Wandeler, Gilles; Owczarek, Marta; Gorgievski, Meri; Dufour, Jean-François; Semmo, Nasser; Zürcher, Samuel (2015). Molecular epidemiology of hepatitis B virus infection in Switzerland: a retrospective cohort study. BMC infectious diseases, 15(1), p. 483. BioMed Central 10.1186/s12879-015-1234-z


Dufour, Jean-François (2014). Hepatology highlights. Hepatology, 60(6), pp. 1803-1805. Wiley Interscience 10.1002/hep.27557

van der Meer, Adriaan J; Wedemeyer, Heiner; Feld, Jordan J; Dufour, Jean-François; Zeuzem, Stefan; Hansen, Bettina E; Janssen, Harry L A (2014). Life expectancy in patients with chronic HCV infection and cirrhosis compared with a general population. JAMA : the journal of the American Medical Association, 312(18), pp. 1927-1928. American Medical Association 10.1001/jama.2014.12627

Beyoglu, Diren; Krausz, K. W.; Martin, Juliette; Maurhofer, Olivier; Dorow, J.; Ceglarek, U.; Gonzalez, F. J.; Dufour, Jean-François; Idle, Jeffrey (2014). Disruption of tumor suppressor gene Hint1 leads to remodeling of the lipid metabolic phenotype of mouse liver. Journal of lipid research, 55(11), pp. 2309-2319. American Society for Biochemistry and Molecular Biology ASBMB 10.1194/jlr.M050682

Dufour, Jean-François (2014). Hepatology highlights. Hepatology, 60(5), pp. 1455-1457. Wiley Interscience 10.1002/hep.27428

Dufour, Jean-François (October 2014). Impact of Lifestyle on NAFLD (Unpublished). In: UEG Annual Meeting. Wien. October 2014.

Dufour, Jean-François (October 2014). Hepatocellular carcinoma: what is new in 2014 (Unpublished). In: UEG Annual Meeting. Wien. October 2014.

Dufour, Jean-François (2014). Hepatology highlights. Hepatology, 60(4), pp. 1119-20. Wiley Interscience 10.1002/hep.27384

Rüeger, S; Bochud, P-Y; Dufour, Jean-François; Müllhaupt, B; Semela, D; Heim, M H; Moradpour, D; Cerny, A; Malinverni, R; Booth, D R; Suppiah, V; George, J; Argiro, L; Halfon, P; Bourlière, M; Talal, A H; Jacobson, I M; Patin, E; Nalpas, B; Poynard, T; ... (2014). Impact of common risk factors of fibrosis progression in chronic hepatitis C. Gut, 64(10), pp. 1605-1615. BMJ Publishing Group 10.1136/gutjnl-2014-306997

Maan, Raoel; van der Meer, Adriaan J; Hansen, Bettina E; Feld, Jordan J; Wedemeyer, Heiner; Dufour, Jean-François; Zangneh, Hooman F; Lammert, Frank; Manns, Michael P; Zeuzem, Stefan; Janssen, Harry L A; de Knegt, Robert J; Veldt, Bart J (2014). Effect of thrombocytopenia on treatment tolerability and outcome in patients with chronic HCV infection and advanced hepatic fibrosis. Journal of hepatology, 61(3), pp. 482-491. Elsevier 10.1016/j.jhep.2014.04.021

Dufour, Jean-François (September 2014). TACE: Who, When, How and How to evaluate? (Unpublished). In: HCC Day. Lausanne. September 2014.

Dufour, Jean-François (2014). Hepatology highlights. Hepatology, 60(3), pp. 773-775. Wiley Interscience 10.1002/hep.27327

Dufour, Jean-François (August 2014). Directly acting antivirals for the treatment of hepatitis C: key messages from phase III tri-als’. (Unpublished). In: Swiss Society for Infectious Diseases. Aarau. August 2014.

Dufour, Jean-François (2014). Hepatology highlights. Hepatology, 60(2), pp. 445-447. Wiley Interscience 10.1002/hep.27270

Liu, Y-L; Patman, G L; Leathart, J B S; Piguet, Anne Christine; Burt, A D; Dufour, Jean-François; Day, C P; Daly, A K; Reeves, H L; Anstee, Q M (2014). Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma. Journal of hepatology, 61(1), pp. 75-81. Elsevier 10.1016/j.jhep.2014.02.030

Dufour, Jean-François (2014). Hepatology highlights. Hepatology, 60(1), pp. 1-3. Wiley Interscience 10.1002/hep.27226

Dufour, Jean-François (June 2014). The ABC of viral Hepatitis (Unpublished). In: UEG Summer school. Prague. June 2014.

Dufour, Jean-François (2014). Hepatology highlights. Hepatology, 59(6), pp. 2059-2061. Wiley Interscience 10.1002/hep.27166

Dufour, Jean-François (2014). Hepatocellular carcinoma: sorafenib: for once age is not an issue. Nature reviews - gastroenterology & hepatology, 11(5), pp. 273-274. Nature Publishing Group 10.1038/nrgastro.2014.48

Dufour, Jean-François (2014). Hepatology highlights. Hepatology, 59(5), pp. 1657-1659. Wiley Interscience 10.1002/hep.27130

Frei, Pascal; Leucht, Anna-Kathrin; Held, Ulrike; Kofmehl, Reto; Manser, Christine N.; Schmitt, Johannes; Mertens, Joachim; Rau, Monika; Baur, Katharina; Gerlach, Tilman; Negro, Francesco; Heim, Markus; Moradpour, Darius; Cerny, Andreas; Dufour, Jean-François; Müllhaupt, Beat; Geier, Andreas (2014). Elderly age is not a negative predictive factor for virological response to therapy with pegylated interferon-α and ribavirin in chronic hepatitis C virus patients. Liver international, 34(4), pp. 551-557. Blackwell Munksgaard 10.1111/liv.12279

Patsenker, Eleanora; Sachse, Philip; Mattsson, Johan; Lanz, Christian; Schneider, Vreni; Brenneisen, Rudolf Max; De Gottardi, Andrea; Dufour, Jean-François; Stickel, Felix; Semmo, Nasser (April 2014). Endocannabinoids Suppress Cytokine Secretion in HCV Infection (Unpublished). In: EASL International Liver Congress 2014. London, UK. 09.-13.04.2014.

De Gottardi, Andrea; Banz Wüthrich, Vanessa; Storni, Federico; Stirnimann, Guido; Semmo, Nasser; Engelmann, C; Piguet, Anne Christine; Whittaker, S; Lammert, F; Berg, T; Zeuzern, S; Cordoba, J; Dufour, Jean-François (April 2014). Safety and Efficacy of an Automated Low Flow Ascites (alfa) Pump in Cirrhotic Patients with Refractory Ascites. In: EASL International Liver Congress 2014. London, UK. 09.-13.04.2014.

Dufour, Jean-François (2014). Hepatology highlights. Hepatology, 59(4), pp. 1217-1219. Wiley Interscience 10.1002/hep.27075

Dufour, Jean-François (2014). Hepatology highlights. Hepatology, 59(3), pp. 743-745. Wiley Interscience 10.1002/hep.27021

Dufour, Jean-François (February 2014). HCC: combination local-systemic therapies (Unpublished). In: EASL Monothematic Conference. Geneva. February 2014.

Dufour, Jean-François (2014). Hepatology highlights. Hepatology, 59(2), pp. 357-359. Wiley Interscience 10.1002/hep.26973

Dufour, Jean-François (2014). Hepatology highlights. Hepatology, 59(1), pp. 1-3. Wiley Interscience 10.1002/hep.26935

Al Hasani, Farah; Knoepfli, Marina; Gemperli, Armin; Kollar, Attila; Banz, Vanessa; Kettenbach, Joachim; Jüni, Peter; Dufour, Jean-François (2014). Factors affecting screening for hepatocellular carcinoma. Annals of hepatology, 13(2), pp. 204-210. Sociedad Mexicana de Hepatologia

Piguet, Anne Christine; Majumder, Syamantak; Maheshwari, Uma; Manjunathan, Reji; Saran, Uttara; Chatterjee, Suvro; Dufour, Jean-François (2014). Everolimus is a potent inhibitor of activated hepatic stellate cell functions in vitro and in vivo , while demonstrating anti-angiogenic activities. Clinical science, 126(11), pp. 775-784. Portland 10.1042/CS20130081

Perazzo, Hugo; Poynard, Thierry; Dufour, Jean-François; Dufour, Jean-François (2014). The Interactions of Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases. Clinics in Liver Disease, 18(1), pp. 233-248. Elsevier 10.1016/j.cld.2013.09.014

Terczyńska-Dyla, Ewa; Bibert, Stephanie; Duong, Francois H. T.; Krol, Ilona; Jørgensen, Sanne; Collinet, Emilie; Kutalik, Zoltán; Aubert, Vincent; Cerny, Andreas; Kaiser, Laurent; Malinverni, Raffaele; Mangia, Alessandra; Moradpour, Darius; Müllhaupt, Beat; Negro, Francesco; Santoro, Rosanna; Semela, David; Semmo, Nasser; Rubbia-Brandt, Laura; Martinetti, Gladys; ... (2014). Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes. Nature communications, 5, p. 5699. Nature Publishing Group 10.1038/ncomms6699

Liu, Yang-Lin; Reeves, Helen L; Burt, Alastair D; Tiniakos, Dina; McPherson, Stuart; Leathart, Julian B S; Allison, Michael E D; Alexander, Graeme J; Piguet, Anne Christine; Anty, Rodolphe; Donaldson, Peter; Aithal, Guruprasad P; Francque, Sven; Van Gaal, Luc; Clement, Karine; Ratziu, Vlad; Dufour, Jean-François; Day, Christopher P; Daly, Ann K and Anstee, Quentin M (2014). TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease. Nature communications, 5(4309), p. 4309. Nature Publishing Group 10.1038/ncomms5309

Dufour, Jean-François (2014). Liver Cancer in Metabolic Diseases (Unpublished). In: UEG Single Topic Conference. Birmingham.

Erös de Bethlenfalva - Hora, Caroline; Mertens, Joachim C.; Piguet, Anne Christine; Kettenbach, Joachim; Schmitt, Johannes; Terracciano, Luigi; Weimann, Rosemarie; Dufour, Jean-François; Geier, Andreas (2014). Radiofrequency ablation suppresses distant tumour growth in a novel rat model of multifocal hepatocellular carcinoma. Clinical science, 126(3), pp. 243-252. Portland 10.1042/CS20130089


Dufour, Jean-François (2013). Hepatology Highlights. Hepatology, 58(6), pp. 1869-1870. Wiley Interscience 10.1002/hep.26780

Ndiaye, Dieynaba; Collado-Hilly, Mauricette; Martin, Juliette; Prigent, Sylvie; Dufour, Jean-François; Combettes, Laurent; Dupont, Geneviève (2013). Characterization of the Effect of the Mitochondrial Protein Hint2 on Intracellular Ca2+ dynamics. Biophysical journal, 105(5), pp. 1268-1275. Biophysical Society 10.1016/j.bpj.2013.06.048

Beyoglu, Diren; Imbeaud, Sandrine; Maurhofer, Olivier; Bioulac-Sage, Paulette; Zucman-Rossi, Jessica; Dufour, Jean-François; Idle, Jeffrey R. (2013). Tissue metabolomics of hepatocellular carcinoma: Tumor energy metabolism and the role of transcriptomic classification. Hepatology, 58(1), pp. 229-238. Wiley Interscience 10.1002/hep.26350

Bibert, Stéphanie; Roger, Thierry; Calandra, Thierry; Bochud, Murielle; Cerny, Andreas; Semmo, Nasser; Duong, François H. T.; Gerlach, Tilman; Malinverni, Raffaele; Moradpour, Darius; Negro, Francesco; Müllhaupt, Beat; Bochud, Pierre-Yves; Swiss Hepatitis C Cohort Study, the; Dufour, Jean-François (2013). IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction. Journal of experimental medicine, 210(6), pp. 1109-1116. Rockefeller University Press 10.1084/jem.20130012

Dufour, Jean-François; Bargellini, I.; De Maria, N.; De Simone, P.; Goulis, I.; Marinho, R. T. (2013). Intermediate hepatocellular carcinoma: current treatments and future perspectives. Annals of oncology, 24(Suppl. 2), ii24-ii29. Oxford University Press 10.1093/annonc/mdt054

Beyoglu, Diren; Dufour, Jean-François; Idle, Jeffrey (February 2013). Lipid metabolomics in hepatocellular carcinoma (Unpublished). In: EASL Monothematic Conference. Luxembourg. Februar 2013.

Rau, Monika; Stickel, Felix; Russmann, Stefan; Manser, Christine N; Becker, Philip P; Weisskopf, Michael; Schmitt, Johannes; Dill, Michael T; Dufour, Jean-François; Moradpour, Darius; Semela, David; Müllhaupt, Beat; Geier, Andreas; Swiss Hepatitis C Cohort Study Group (SCCS), (2013). Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum level, hemoglobin drop and therapeutic response in patients with HCV infection. Journal of hepatology, 58(4), pp. 669-75. Amsterdam: Elsevier 10.1016/j.jhep.2012.11.027

Leichtle, Alexander Benedikt; Dufour, Jean-François; Fiedler, Martin (2013). Potentials and pitfalls of clinical peptidomics and metabolomics. Swiss medical weekly, 143, w13801. EMH Schweizerischer Ärzteverlag 10.4414/smw.2013.13801

Röther, Mareike; Dufour, Jean-François; Schnüriger, Beat (2013). An Uncommon Cause of a Focal Liver Lesion. Gastroenterology, 144(3), pp. 510-659. Elsevier 10.1053/j.gastro.2012.10.017

van der Meer, A. J.; Veldt, B. J.; Feld, J. J.; Wedemeyer, H.; Dufour, Jean-François; Lammert, F.; Duarte-Rojo, A.; Manns, M. P.; Zeuzem, S.; Hofmann, W. P.; de Knegt, R. J.; Hansen, B. E.; Janssen, H. L. A. (2013). The number needed to treat to prevent mortality and cirrhosis-related complications among patients with cirrhosis and HCV genotype 1 infection. Journal of viral hepatitis, 21(8), pp. 568-577. Blackwell Science 10.1111/jvh.12185

Tonko, Sebastian; Dufour, Jean-François (2013). Hepatologische Scores. Therapeutische Umschau, 70(10), pp. 577-579. Huber 10.1024/0040-5930/a000450

Lange, Christian M.; Miki, Daiki; Ochi, Hidenori; Nischalke, Hans-Dieter; Bojunga, Jörg; Bibert, Stéphanie; Morikawa, Kenichi; Gouttenoire, Jérôme; Cerny, Andreas; Dufour, Jean-François; Gorgievski, Meri; Heim, Markus H.; Malinverni, Raffaele; Müllhaupt, Beat; Negro, Francesco; Semela, David; Kutalik, Zoltan; Müller, Tobias; Spengler, Ulrich; Berg, Thomas; ... (2013). Genetic Analyses Reveal a Role for Vitamin D Insufficiency in HCV-Associated Hepatocellular Carcinoma Development. PLoS ONE, 8(5), e64053. Public Library of Science 10.1371/journal.pone.0064053

Lange, Christian M.; Bibert, Stéphanie; Dufour, Jean-François; Cellerai, Cristina; Cerny, Andreas; Heim, Markus H.; Kaiser, Laurent; Malinverni, Raffaele; Müllhaupt, Beat; Negro, Francesco; Semela, David; Moradpour, Darius; Kutalik, Zoltán; Bochud, Pierre-Yves (2013). Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma. Journal of hepatology, 59(3), pp. 504-509. Elsevier 10.1016/j.jhep.2013.04.032

Thattil, Raphael; Dufour, Jean-François (2013). Hepatocellular carcinoma in a non-cirrhotic patient with Wilson's disease. World journal of gastroenterology, 19(13), pp. 2110-2113. WJG Press 10.3748/wjg.v19.i13.2110

Dufour, Jean-François (2013). Modern Hepatomancy. Gastroenterology, 144(5), pp. 876-878. Elsevier 10.1053/j.gastro.2013.03.015

Majumder, Syamantak; Piguet, Anne Christine; Dufour, Jean-François; Chatterjee, Suvro (2013). Study of the cellular mechanism of Sunitinib mediated inactivation of activated hepatic stellate cells and its implications in angiogenesis. European journal of pharmacology, 705(1-3), pp. 86-95. Elsevier 10.1016/j.ejphar.2013.02.026

Dufour, Jean-François (2013). C-reactive protein, a prognostic marker in hepatocellular carcinoma. Hepatology, 57(6), pp. 2103-2105. Wiley Interscience 10.1002/hep.26250


Bochud, Pierre-Yves; Bibert, Stéphanie; Kutalik, Zoltán; Patin, Etienne; Guergnon, Julien; Nalpas, Bertrand; Goossens, Nicolas; Kuske, Lorenz; Müllhaupt, Beat; Gerlach, Tillman; Heim, Markus H; Moradpour, Darius; Cerny, Andreas; Malinverni, Raffaele; Regenass, Stephan; Dollenmaier, Guenter; Hirsch, Hans; Martinetti, Gladys; Gorgiewski, Meri; Bourlière, Marc; ... (2012). IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes. Hepatology, 55(2), pp. 384-94. Hoboken, N.J.: Wiley Interscience 10.1002/hep.24678

St-Pierre, Marie V; Dufour, Jean-François (2012). Biomarkers for Hepatocellular Apoptosis in the Management of Liver Diseases. Current pharmaceutical biotechnology, 13(11), pp. 2221-7. Hilversum: Bentham Science Publishers

Martin, Juliette; Maurhofer, Olivier; Bellance, Nadège; Benard, Giovanni; Graber, Franziska; Hahn, Dagmar Karen; Galinier, Anne; Hora, Caroline; Gupta, Anirudh; Ferrand, Gisèle; Hoppeler, Hans; Rossignol, Rodrigue; Dufour, Jean-François; St-Pierre, Marie V (2012). Disruption of the histidine triad nucleotide-binding hint2 gene in mice affects glycemic control and mitochondrial function. Hepatology, 57(5), pp. 2037-2048. Hoboken, N.J.: Wiley Interscience 10.1002/hep.26060

Bürgi, Anne-Catherine; Dufour, Jean-François (2012). [Treatment of nonalcoholic steatohepatitis]. Revue du praticien, 62(10), pp. 1425-7. Neuilly-sur-Seine: Global Média Santé

Bolondi, Luigi; Burroughs, Andrew; Dufour, Jean-François; Galle, Peter R; Mazzaferro, Vincenzo; Piscaglia, Fabio; Raoul, Jean Luc; Sangro, Bruno (2012). Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions. Seminars in liver disease, 32(4), pp. 348-59. New York, N.Y.: Thieme Medical Publishers 10.1055/s-0032-1329906

van der Meer, Adriaan J; Veldt, Bart J; Feld, Jordan J; Wedemeyer, Heiner; Dufour, Jean-François; Lammert, Frank; Duarte-Rojo, Andres; Heathcote, E Jenny; Manns, Michael P; Kuske, Lorenz; Zeuzem, Stefan; Hofmann, W Peter; de Knegt, Robert J; Hansen, Bettina E; Janssen, Harry L A (2012). Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA - the journal of the American Medical Association, 308(24), pp. 2584-93. Chicago, Ill.: American Medical Association 10.1001/jama.2012.144878

Liechti, Fabia; Dufour, Jean-François (2012). Treatment of NASH with ursodeoxycholic acid: cons. Clinics and research in hepatology and gastroenterology, 36 Suppl 1, S46-52. Paris: Elsevier Masson 10.1016/S2210-7401(12)70021-9

Kuske, Lorenz; Mensen, Armand; Müllhaupt, Beat; Negro, Francesco; Semela, David; Moradpour, Darius; Malé, Pierre Jean; Heim, Markus H; Malinverni, Raffaele; Cerny, Andreas; Dufour, Jean-François; Swiss Hepatitis C Cohort Study, (2012). Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma. Swiss medical weekly, 142, w13651. Muttenz: EMH Schweizerischer Ärzteverlag 10.4414/smw.2012.13651

Patin, Etienne; Kutalik, Zoltán; Guergnon, Julien; Bibert, Stéphanie; Nalpas, Bertrand; Jouanguy, Emmanuelle; Munteanu, Mona; Bousquet, Laurence; Argiro, Laurent; Halfon, Philippe; Boland, Anne; Müllhaupt, Beat; Semela, David; Dufour, Jean-François; Heim, Markus H; Moradpour, Darius; Cerny, Andreas; Malinverni, Raffaele; Hirsch, Hans; Martinetti, Gladys; ... (2012). Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection. Gastroenterology, 143(5), 1244-52.e1-12. Philadelphia, Pa.: Elsevier 10.1053/j.gastro.2012.07.097

Lange, Christian M; Bibert, Stephanie; Kutalik, Zoltan; Burgisser, Philippe; Cerny, Andreas; Dufour, Jean-François; Geier, Andreas; Gerlach, Tilman J; Heim, Markus H; Malinverni, Raffaele; Negro, Francesco; Regenass, Stephan; Badenhoop, Klaus; Bojunga, Jörg; Sarrazin, Christoph; Zeuzem, Stefan; Müller, Tobias; Berg, Thomas; Bochud, Pierre-Yves; Moradpour, Darius; ... (2012). A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis C. PLoS ONE, 7(7), e40159. Lawrence, Kans.: Public Library of Science 10.1371/journal.pone.0040159

Sieghart, Wolfgang; Pinter, Matthias; Dauser, Bernhard; Rohr-Udilova, Natalya; Piguet, Anne-Christine; Prager, Gerald; Hayden, Hubert; Dienes, Hans-Peter; Dufour, Jean-François; Peck-Radosavljevic, Markus (2012). Erlotinib and sorafenib in an orthotopic rat model of hepatocellular carcinoma. Journal of hepatology, 57(3), pp. 592-9. Amsterdam: Elsevier 10.1016/j.jhep.2012.04.034

Dufour, Jean-François (2012). Anti-angiogenic therapy for HCC. Minerva medica, 58(1), pp. 81-6. Torino: Minerva Medica

Dufour, Jean-François (2012). TACE with or without systemic therapy? Journal of hepatology, 56(6), pp. 1224-5. Amsterdam: Elsevier 10.1016/j.jhep.2012.01.006

Dufour, Jean-François; Le Gallou, Thomas; Cordier, Jean-François; Aumaître, Olivier; Pinède, Laurent; Aslangul, Elisabeth; Pagnoux, Christian; Marie, Isabelle; Puéchal, Xavier; Decaux, Olivier; Dubois, Alain; Agard, Christian; Mahr, Alfred; Comoz, François; Boutemy, Jonathan; Broussolle, Christiane; Guillevin, Loïc; Sève, Pascal; Bienvenu, Boris; French Center-East Internists Group, ; ... (2012). Urogenital manifestations in Wegener granulomatosis: a study of 11 cases and review of the literature. Medicine, 91(2), pp. 67-74. Baltimore, Md.: Lippincott Williams & Wilkins 10.1097/MD.0b013e318239add6

Lange, Christian M; Kutalik, Zoltan; Morikawa, Kenichi; Bibert, Stéphanie; Cerny, Andreas; Dollenmaier, Günter; Dufour, Jean-François; Gerlach, Tilman J; Heim, Markus H; Malinverni, Raffaele; Müllhaupt, Beat; Negro, Francesco; Moradpour, Darius; Bochud, Pierre-Yves; Swiss Hepatitis C Cohort Study Group, (2012). Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy. Hepatology, 55(4), pp. 1038-47. Hoboken, N.J.: Wiley Interscience 10.1002/hep.24787

Girardin, F; Daali, Y; Gex-Fabry, M; Rebsamen, M; Roux-Lombard, P; Cerny, A; Bihl, F; Binek, J; Moradpour, D; Negro, F; Desmeules, J; Swiss Hepatitis C Cohort Study Group, (2012). Liver kidney microsomal type 1 antibodies reduce the CYP2D6 activity in patients with chronic hepatitis C virus infection. Journal of viral hepatitis, 19(8), pp. 568-73. Oxford: Blackwell Science 10.1111/j.1365-2893.2011.01578.x

EASL, (2012). EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. European journal of cancer, 2012(48 (5)), pp. 599-641. Amsterdam: Elsevier 10.1016/j.ejca.2011.12.021

Baur, Katharina; Mertens, Joachim C; Schmitt, Johannes; Iwata, Rika; Stieger, Bruno; Frei, Pascal; Seifert, Burkhardt; Bischoff Ferrari, Heike A; von Eckardstein, Arnold; Müllhaupt, Beat; Geier, Andreas; Swiss Hepatitis C Cohort Study Group, (2012). The vitamin D receptor gene bAt (CCA) haplotype impairs the response to pegylated-interferon/ribavirin-based therapy in chronic hepatitis C patients. Antiviral therapy, 17(3), pp. 541-7. London: International Medical Press 10.3851/IMP2018


Piguet, Anne-Christine; Saar, Bettina; Hlushchuk, Ruslan; St-Pierre, Marie V; McSheehy, Paul M J; Radojevic, Vesna; Afthinos, Maresa; Terracciano, Luigi; Djonov, Valentin; Dufour, Jean-François (2011). Everolimus augments the effects of sorafenib in a syngeneic orthotopic model of hepatocellular carcinoma. Molecular cancer therapeutics, 10(6), pp. 1007-17. Philadelphia, Pa.: American Association for Cancer Research AACR 10.1158/1535-7163.MCT-10-0666

Patterson, Andrew D; Maurhofer, Olivier; Beyoglu, Diren; Lanz, Christian; Krausz, Kristopher W; Pabst, Thomas; Gonzalez, Frank J; Dufour, Jean-François; Idle, Jeffrey R (2011). Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling. Cancer research, 71(21), pp. 6590-600. Birmingham, Ala.: American Association for Cancer Research AACR 10.1158/0008-5472.CAN-11-0885

Morell, Bernhard; Dufour, Jean-François (2011). [Liver transplantation - when and for whom it should be performed]. Therapeutische Umschau, 68(12), pp. 707-13. Bern: Huber 10.1024/0040-5930/a000234

Yao, Francis Y; Breitenstein, Stefan; Broelsch, Christoph E; Dufour, Jean-François; Sherman, Morris (2011). Does a patient qualify for liver transplantation after the down-staging of hepatocellular carcinoma? Liver transplantation, 17 Suppl 2, S109-S116. Hoboken, N.J.: Wiley 10.1002/lt.22335

Balmer, Maria Luisa; Dufour, Jean-François (2011). [Non-alcoholic steatohepatitis - from NAFLD to MAFLD]. Therapeutische Umschau, 68(4), pp. 183-8. Bern: Huber 10.1024/0040-5930/a000148

Martin, Juliette; St-Pierre, Marie V; Dufour, Jean-François (2011). Hit proteins, mitochondria and cancer. Biochimica et biophysica acta - bioenergetics, 1807(6), pp. 626-32. Amsterdam: Elsevier 10.1016/j.bbabio.2011.02.001

Hora, Caroline; Romanque, Pamela; Dufour, Jean-François (2011). Effect of sorafenib on murine liver regeneration. Hepatology, 53(2), pp. 577-86. Hoboken, N.J.: Wiley Interscience 10.1002/hep.24037

Cai, Tao; Dufour, Jean-François; Muellhaupt, Beat; Gerlach, Tilman; Heim, Markus; Moradpour, Darius; Cerny, Andreas; Malinverni, Raffaele; Kaddai, Vincent; Bochud, Murielle; Negro, Francesco; Bochud, Pierre-Yves; Swiss Hepatitis C Cohort Study Group, (2011). Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosis. Journal of hepatology, 55(3), pp. 529-35. Amsterdam: Elsevier 10.1016/j.jhep.2010.12.020

Piguet, Anne-Christine; Dufour, Jean-François (2011). PI(3)K/PTEN/AKT pathway. Journal of hepatology, 54(6), pp. 1317-9. Amsterdam: Elsevier 10.1016/j.jhep.2010.12.013

Haedrich, Marion; Dufour, Jean-François (2011). UDCA for NASH: end of the story? Journal of hepatology, 54(5), pp. 856-8. Amsterdam: Elsevier 10.1016/j.jhep.2010.10.009

Martin, Juliette; Romanque, Pamela; Maurhofer, Olivier; Schmitter, Karin; Hora, Caroline; Ferrand, Gisèle; Dufour, Jean-François (2011). Ablation of the tumor suppressor histidine triad nucleotide binding protein 1 is protective against hepatic ischemia/reperfusion injury. Hepatology, 53(1), pp. 243-52. Hoboken, N.J.: Wiley Interscience 10.1002/hep.23978

Martin, Juliette; Dufour, Jean-François (2011). Abnormal nitrosothiol metabolism in hepatocellular carcinoma. Journal of hepatology, 54(3), pp. 579-80. Amsterdam: Elsevier 10.1016/j.jhep.2010.10.011

Van der Meer, AJ; Veldt, BJ; Feld, JJ; Wedemeyer, H; Dufour, Jean-François; Lammert, F; Duarte-Rojo, A; Heathcote, EJ; Manns, MP; Kuske, L; Zeuzem, S; Hofmann, WP; de Knegt, RJ; Hansen, BE; Janssen, HL (2011). Sustained Virological Response Improves Overall Survival in Chronic Hepatitis C Patients with Advanced Fibrosis. Hepatology, 54(1), 441A-441A. Hoboken, N.J.: Wiley Interscience

Van der Meer, AJ; Veldt, BJ; Feld, JJ; Wedemeyer, H; Dufour, Jean-François; Lammert, F; Duarte-Rojo, A; Heathcote, EJ; Manns, MP; Kuske, L; Zeuzem, S; Hofmann, WP; de Knegt, RJ; Hansen, BE; Janssen, HL (2011). Improved Platelet Count and Smaller Spleen Size Long After Sustained Virological Response in Chronic Hepatitis C Patients With Advance Fibrosis. Hepatology, 54(1), 820A-820A. Hoboken, N.J.: Wiley Interscience

Frei, P; Leucht, AK; Held, U; Kofmehl, R; Schmitt, J; Rau, M; Gerlach, T; Negro, F; Heim, MH; Moradpour, D; Cerny, A; Dufour, Jean-François; Mullhaupt, B; Geier, A (2011). Age Above 60 Years Is Not a Negative Predictive Factor For Combined Antiviral Therapy With Pegylated Interferon Alpha and Ribavirin in Hepatitis C Patients. Hepatology, 54(1), 826A-826A. Hoboken, N.J.: Wiley Interscience

Lange, CM; Bibert, S; Kutalik, Z; Morikawa, K; Cerny, A; Dufour, Jean-François; Gerlach, TJ; Heim, MH; Malinverni, R; Muellhaupt, B; Negro, F; Badenhoop, K; Sarrazin, C; Berg, T; Gouttenoire, J; Bochud, PY; Moradpour, D (2011). Swiss Hepatitis C Cohort Study. A Large Scale Genetic Validation Study Coupled With In-Vitro Analysis Reveal a Role of Vitamin D-Signaling in the Pathogenesis and Treatment of Chronic Hepatitis C. Hepatology, 54(1), p. 537. Hoboken, N.J.: Wiley Interscience 10.1016/S0168-8278(11)61359-7

Bochud, PY; Bibert, S; Kutalik, Z; Patin, E; Guergnon, J; Nalpas, B; Goossens, N; Kuske, L; Müllhaup, B; Gerlach, T; Heim, MH; Moradpour, D; Cerny, A; Malinverni, R; Regenass, S; Dollenmaier, G; Hirsch, H; Martinetti, G; Gorgiewski, M; Boulière, M; ... (2011). Swiss Hepatitis C Cohort Study Grp. IL28B Polymorphisms Linked to Poor Response To Treatment are Associated with Low Necroinflammatory Activity and Slow Fibrosis Progression in HCV Genotype Non-1-Infected patientsBern. Hepatology, 54(1), p. 539. Hoboken, N.J.: Wiley Interscience 10.1016/S0168-8278(11)61363-9

Hora, C; Mertens, J; Saar, B; Kettenbach, J; Ledermann, M; C Piguet, A; Mertens, S; Schmitt, J; F Dufour, J; Geier, A (2011). Effects of Radiofrequency Ablation (RFA) In Combination With Sorafenib In a 2-Tumor Rat Model of Hepatocellular Carcinoma. Hepatology, 54(1), p. 89. Hoboken, N.J.: Wiley Interscience 10.1016/S0168-8278(11)60213-4

Lange, CM; Kutalik, Z; Morikawa, K; Bibert, S; Cerny, A; Dollenmaier, G; Dufour, Jean-François; Gerlach, TJ; Heim, MH; Malinverni, R; Müllhaupt, B; Negro, F; Moradpour, D; Bochud, PY (2011). the Swiss Hepatitis C Cohort Study Group. Hepatology Hoboken, N.J.: Wiley Interscience


Dufour, Jean-François (2010). Treat the bones and get less rejection! Liver international, 30(3), pp. 337-8. Oxford: Blackwell Munksgaard 10.1111/j.1478-3231.2009.02189.x

Dufour, Jean-François; Johnson, Philip (2010). Liver cancer: from molecular pathogenesis to new therapies: summary of the EASL single topic conference. Journal of hepatology, 52(2), pp. 296-304. Amsterdam: Elsevier

Piguet, Anne-Christine; Stroka, Deborah; Zimmermann, Arthur; Dufour, Jean-François (2010). Hypoxia aggravates non-alcoholic steatohepatitis in mice lacking hepatocellular PTEN. Clinical science, 118(6), pp. 401-10. London: Portland 10.1042/CS20090313

Seitz, M; Reichenbach, S; Möller, B; Zwahlen, M; Villiger, PM; Dufour, Jean-François (2010). Hepatoprotective effect of tumour necrosis factor alpha blockade in psoriatic arthritis: a cross-sectional study. Annals of the rheumatic diseases, 69(6), pp. 1148-1150. London: BMJ Publishing Group 10.1136/ard.2009.116194

Dufour, Jean-François; Hoppe, Hanno; Heim, Markus H; Helbling, Beat; Maurhofer, Olivier; Szucs-Farkas, Zsolt; Kickuth, Ralph; Borner, Markus; Candinas, Daniel; Saar, Bettina (2010). Continuous administration of sorafenib in combination with transarterial chemoembolization in patients with hepatocellular carcinoma: results of a phase I study. Oncologist, 15(11), pp. 1198-204. Miamisburg, Ohio: AlphaMed Press 10.1634/theoncologist.2010-0180

Dufour, Jean-François (2010). Vitamin E for nonalcoholic steatohepatitis: ready for prime time? Hepatology, 52(2), pp. 789-792. Hoboken, N.J.: Wiley Interscience 10.1002/hep.23817

Rauch, Andri; Kutalik, Zoltán; Descombes, Patrick; Cai, Tao; Di Iulio, Julia; Mueller, Tobias; Bochud, Murielle; Battegay, Manuel; Bernasconi, Enos; Borovicka, Jan; Colombo, Sara; Cerny, Andreas; Dufour, Jean-François; Furrer, Hansjakob; Günthard, Huldrych F; Heim, Markus; Hirschel, Bernard; Malinverni, Raffaele; Moradpour, Darius; Müllhaupt, Beat; ... (2010). Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology, 138(4), 1338-45, 1345.e1-7. Philadelphia, Pa.: Elsevier 10.1053/j.gastro.2009.12.056

Balmer, ML; F.Dufour, J. (2010). Molecular mechanisms of liver cancer metastasis. Bantham Publishers

Balmer, ML; Joneli, J; Schoepfer, A; Stickel, F; Thormann, W; Dufour, Jean-François (2010). Significance of serum adiponection levels in patients with chronic liver disease. Clinical science, 119(10), pp. 431-36. London: Portland 10.1042/CS20100008

Chtiou, H; Mauerhofer, O; Günther, B; Dufour, Jean-François (2010). Macro-AST in an asymptomatic young patient. Annals of hepatology, 9(1), pp. 93-5. México City: Sociedad Mexicana de Hepatologia

Overbeck, K; Dufour, Jean-François; Müllhaupt, B; Helbling, B; Borovicka, J; Malinverni, R; Heim, M; Moradpur, D; Cerny, A; Rickenbach, M; Negro, F (2010). Impact of international consensus guidelines on atniviral therapy of chronic hepatitis C patients in Switzerland. Swiss medical weekly Muttenz: EMH Schweizerischer Ärzteverlag

Hora, C; Dufour, Jean-François (2010). Primary Hepatocellular Carcinoma 5. Berlin-Heidelberg: Springer 10.1007/978-1-4419-7107-4_56

Balmer, ML; Dufour, Jean-François (2010). Biology of Hepatocellular Carcinoma. New York: Humana Press 10.1007/978-1-60327-522-4_2

Sendensy, A; Dufour, Jean-François (2010). Physiology of Liver Functions. Berlin-Heidelberg: Springer


Dinges, S; Morard, I; Heim, M; Dufour, Jean-François; Müllhaupt, B; Giostra, E; Clavien, P-A; Mentha, G; Negro, F (2009). Pegylated interferon-alpha2a/ribavirin treatment of recurrent hepatitis C after liver transplantation. Transplant infectious disease, 11(1), pp. 33-9. Hoboken, N.J.: Wiley 10.1111/j.1399-3062.2008.00359.x

Dufour, Jean-François (2009). The evasive promise of antiangiogenic therapy. Journal of hepatology, 51(5), pp. 970-2. Amsterdam: Elsevier

Bochud, Pierre-Yves; Cai, Tao; Overbeck, Kathrin; Bochud, Murielle; Dufour, Jean-François; Müllhaupt, Beat; Borovicka, Jan; Heim, Markus; Moradpour, Darius; Cerny, Andreas; Malinverni, Raffaele; Francioli, Patrick; Negro, Francesco (2009). Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C. Journal of hepatology, 51(4), pp. 655-66. Amsterdam: Elsevier 10.1016/j.jhep.2009.05.016

Balmer, Maria Luisa; Siegrist, Kathrin; Zimmermann, Arthur; Dufour, Jean-François (2009). Effects of ursodeoxycholic acid in combination with vitamin E on adipokines and apoptosis in patients with nonalcoholic steatohepatitis. Liver international, 29(8), pp. 1184-8. Oxford: Blackwell Munksgaard 10.1111/j.1478-3231.2009.02037.x

Lepper, P M; Dufour, Jean-François (2009). [Elevated transaminases - what to do if everything was done?]. Praxis - schweizerische Rundschau für Medizin, 98(6), pp. 330-4. Bern: Huber

Prasad, Leonie; Spicher, V M; Negro, F; Rickenbach, M; Dufour, Jean-François (2009). Little evidence that hepatitis C virus leads to a higher risk of mortality in the absence of cirrhosis and excess alcohol intake: the Swiss Hepatitis C Cohort Study. Journal of viral hepatitis, 16(9), pp. 644-649. Oxford: Blackwell Science 10.1111/j.1365-2893.2009.01113.x

Dufour, Jean-François; Pradat, Pierre; Ruivard, Marc; Hot, Arnaud; Dumontet, Charles; Broussolle, Christiane; Trepo, Christian; Sève, Pascal (2009). Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 16 cases. European journal of gastroenterology & hepatology, 21(3), pp. 245-53. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/MEG.0b013e3283249908


Roh, V; Laemmle, A; Von Holzen, U; Stroka, D; Dufour, Jean-François; Hunt, K K; Candinas, D; Vorburger, S A (2008). Dual induction of PKR with E2F-1 and IFN-alpha to enhance gene therapy against hepatocellular carcinoma. Cancer gene therapy, 15(10), pp. 636-44. New York, N.Y.: Nature Publishing Group 10.1038/cgt.2008.34

Romanque, Pamela; Stickel, Felix; Dufour, Jean-François (2008). Disproportionally high results of transient elastography in patients with autoimmune hepatitis. Liver international, 28(8), pp. 1177-8. Oxford: Blackwell Munksgaard 10.1111/j.1478-3231.2008.01743.x

Balmer, Maria Luisa; Dufour, Jean-François (2008). Treatment of hypercholesterolemia in patients with primary biliary cirrhosis might be more beneficial than indicated. Swiss medical weekly, 138(29-30), pp. 415-9. Muttenz: EMH Schweizerischer Ärzteverlag

Lenglet, Sébastien; Antigny, Fabrice; Vetterli, Laurène; Dufour, Jean-François; Rossier, Michel F (2008). Hint2 is expressed in the mitochondria of H295R cells and is involved in steroidogenesis. Endocrinology, 149(11), pp. 5461-9. Chevy Chase, Md.: Endocrine Society 10.1210/en.2008-0400

Piguet, Anne-Christine; Semela, David; Keogh, Adrian; Wilkens, Ludwig; Stroka, Deborah; Stoupis, Christoforos; St-Pierre, Marie V; Dufour, Jean-François (2008). Inhibition of mTOR in combination with doxorubicin in an experimental model of hepatocellular carcinoma. Journal of hepatology, 49(1), pp. 78-87. Amsterdam: Elsevier 10.1016/j.jhep.2008.03.024

Strebel, Bruno M; Dufour, Jean-François (2008). Combined approach to hepatocellular carcinoma: a new treatment concept for nonresectable disease. Expert review of anticancer therapy, 8(11), pp. 1743-9. London: Expert Reviews 10.1586/14737140.8-11.1743

Helbling, B; Overbeck, K; Gonvers, J-J; Malinverni, R; Dufour, Jean-François; Borovicka, J; Heim, M; Cerny, A; Negro, F; Bucher, S; Rickenbach, M; Renner, E L; Mullhaupt, B (2008). Host- rather than virus-related factors reduce health-related quality of life in hepatitis C virus infection. Gut, 57(11), pp. 1597-603. London: BMJ Publishing Group 10.1136/gut.2007.142844

Martin, Juliette; Dufour, Jean-François (2008). Tumor suppressor and hepatocellular carcinoma. World journal of gastroenterology, 14(11), pp. 1720-33. Beijing (China): WJG Press 10.3748/wjg.14.1720

Romanque, Pamela; Piguet, Anne-Christine; Dufour, Jean-François (2008). Targeting vessels to treat hepatocellular carcinoma. Clinical science, 114(7), pp. 467-77. London: Portland 10.1042/CS20070310

Hora, Caroline; Negro, Francesco; Leandro, Giacchino; Oneta, Carl M; Rubbia-Brandt, Laura; Muellhaupt, Beat; Helbling, Beat; Malinverni, Raffaele; Gonvers, Jean-Jacques; Dufour, Jean-François (2008). Connective tissue growth factor, steatosis and fibrosis in patients with chronic hepatitis C. Liver international, 28(3), pp. 370-6. Oxford: Blackwell Munksgaard 10.1111/j.1478-3231.2007.01608.x


Dufour, Jean-François (2007). Met-thodology. Journal of hepatology, 46(4), pp. 748-9. Amsterdam: Elsevier

Plock, Jan; Frese, Steffen; Keogh, Adrian; Bisch-Knaden, Sonja; Ayuni, Erick; Corazza, Nadia; Weikert, Christian; Jakob, Stephan; Erni, Dominique; Dufour, Jean-François; Brunner, Thomas; Candinas, Daniel; Stroka, Deborah (2007). Activation of non-ischemic, hypoxia-inducible signalling pathways up-regulate cytoprotective genes in the murine liver. Journal of hepatology, 47(4), pp. 538-45. Amsterdam: Elsevier 10.1016/j.jhep.2007.04.016

Chtioui, Haithem; Semela, David; Ledermann, Monika; Zimmermann, Arthur; Dufour, Jean-François (2007). Expression and activity of the cytochrome P450 2E1 in patients with nonalcoholic steatosis and steatohepatitis. Liver international, 27(6), pp. 764-71. Oxford: Blackwell Munksgaard 10.1111/j.1478-3231.2007.01524.x

Banz, Yara; Inderbitzin, Daniel; Seiler, Christian A; Schmid, Stefan W; Dufour, Jean-François; Zimmermann, Arthur; Mohaçsi, Paul; Candinas, Daniel (2007). Bridging hyperacute liver failure by ABO-incompatible auxiliary partial orthotopic liver transplantation. Transplant international, 20(8), pp. 722-7. Oxford: Wiley-Blackwell 10.1111/j.1432-2277.2007.00512.x

Dufour, Jean-François; Huber, Otmar; Kozma, Sara C; Lu, Xin; Toftgård, Rune (2007). Tumour suppressors in liver carcinogenesis. Journal of hepatology, 47(6), pp. 860-7. Amsterdam: Elsevier 10.1016/j.jhep.2007.09.003

Dufour, Jean-François (2007). NASH and thiazolidinediones: not to be taken lightly. Journal of hepatology, 47(4), pp. 451-453. Amsterdam: Elsevier 10.1016/j.jhep.2007.07.012

Semela, David; Piguet, Anne-Christine; Kolev, Mirjam; Schmitter, Karin; Hlushchuk, Ruslan; Djonov, Valentin; Stoupis, Christoforos; Dufour, Jean-François (2007). Vascular remodeling and antitumoral effects of mTOR inhibition in a rat model of hepatocellular carcinoma. Journal of hepatology, 46(5), pp. 840-8. Amsterdam: Elsevier 10.1016/j.jhep.2006.11.021

Roth, Patrik; Hammer, Caroline; Piguet, Anne-Christine; Ledermann, Monika; Dufour, Jean-François; Waelti, Ernst (2007). Effects on hepatocellular carcinoma of doxorubicin-loaded immunoliposomes designed to target the VEGFR-2. Journal of drug targeting, 15(9), pp. 623-31. London: Informa Healthcare 10.1080/10611860701502723

Banz Wälti, Yara; Rieben, R; Inderbitzin, D; Seiler, C; Schmid, S; Dufour, Jean-François; Smith, R; Nydegger, U; Zimmermann, A; Mohacsi, P; Candinas, Daniel (2007). Immunological preconditioning, including local complement inhibition, in ABO-incompatible auxiliary partial orthotopic liver transplantation as a bridge to definitive grafting in hyperacute liver failure: First report of a successful strategy. Molecular immunology, 44(1-3), pp. 153-154. Amsterdam: Elsevier 10.1016/j.molimm.2006.07.020

Keogh-Stroka, Deborah M.; Trochsler, M; Hlushchuk, R; Baum, O; Candinas, Daniel; Dufour, Jean-François; Djonov, V (2007). Sinusoidal duplication by intussusception is an early event in liver regeneration after partial hepatectomy. Journal of hepatology, 46(46), S146. Amsterdam: Elsevier 10.1016/S0168-8278(07)61974-6

Piguet, A; Ledermann, C; Zimmermann, A; Keogh-Stroka, Deborah M.; Dufour, Jean-François (2007). Hypoxia worsens non-alcoholic steatohepatitis. Journal of hepatology, 46(46), S10. Amsterdam: Elsevier 10.1016/S0168-8278(07)61616-X


Dufour, Jean-François; Oneta, CM; Gonvers, JJ; Bihl, F; Cerny, A; Cereda, JM; Zala, JF; Helbling, B; Steuerwald, M; Zimmermann, A; Swiss, Association for the Study of the Liver (2006). Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis. Clinical gastroenterology and hepatology, 4(12), pp. 1537-43. Philadelphia, Pa.: Elsevier 10.1016/j.cgh.2006.09.025

Barth, Florian; Gerber, Peter J; Reichen, Jürg; Dufour, Jean-François; Nicod, Laurent P (2006). Efficiency and safety of bosentan in child C cirrhosis with portopulmonary hypertension and renal insufficiency. European journal of gastroenterology & hepatology, 18(10), pp. 1117-9. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/01.meg.0000231749.60889.f7

Martin, Juliette; Magnino, Fabrice; Schmidt, Karin; Piguet, Anne-Christine; Lee, Ju-Seog; Semela, David; St-Pierre, Marie V; Ziemiecki, Andrew; Cassio, Doris; Brenner, Charles; Thorgeirsson, Snorri S; Dufour, Jean-François (2006). Hint2, a mitochondrial apoptotic sensitizer down-regulated in hepatocellular carcinoma. Gastroenterology, 130(7), pp. 2179-88. Philadelphia, Pa.: Elsevier 10.1053/j.gastro.2006.03.004

De Gottardi, Andrea; Dufour, Jean-François (2006). [Oesophageal and fundic variceal bleeding]. Therapeutische Umschau, 63(5), pp. 295-9. Bern: Huber

Dufour, Jean-François; Fey, Martin F (2006). What is the current treatment of PTLD after liver transplantation? Journal of hepatology, 44(1), pp. 23-6. Amsterdam: Elsevier 10.1016/j.jhep.2005.10.009

Keogh-Stroka, Deborah M.; Plock, Jan Alexander; Beldi, Guido; Frese, Steffen R.; Keogh, Adrian; Bisch-Knaden, Sonja Maria; Dufour, Jean-François; Brunner, Thomas; Candinas, Daniel (2006). Temporary hypoxic stress protects the liver from Fas-mediated apoptosis and ischemia reperfusion injury. In: 93. Jahreskongress der Schweizerischen Gesellschaft für Chirurgie. Lugano, Switzerland. 21.-23.6.2006.


Guenat, O T; Boulard, G; Dufour, Jean-François; de Rooij, N F; Koudelka-Hep, M (2004). Development of a multifunctional platform for extra- and intracellular ionic activities recording. IEEE Engineering in Medicine and Biology Society conference proceedings, 4, pp. 2546-2548. Piscataway, N.J.: IEEE Service Center

Provide Feedback